Showing results (1071-1080 of 5,723) with videos related to
Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|January 7, 2017
RNAi-mediated knockdown of MCM7 gene on CML cells and its therapeutic potential for leukemiaLiang Tian, Juan Liu, Guo-Hua Xia, et al.Medical Oncology (Northwood, London, England)|January 7, 2017
IL-33 acts as a foe to MIA PaCa-2 pancreatic cancerYujiang Fang, Lei Zhao, Huaping Xiao, et al.Medical Oncology (Northwood, London, England)|February 1, 2017
Risk of tumor flare after nivolumab treatment in patients with irradiated field recurrenceTatsuya Yoshida, Hiromi Furuta, Toyoaki HidaMedical Oncology (Northwood, London, England)|February 6, 2017
Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancerGiuseppe Belfiore, Maria Paola Belfiore, Alfonso Reginelli, et al.Medical Oncology (Northwood, London, England)|December 1, 2016
Assessment of oxidative/nitrative modifications of plasma proteins, selected ROTEM parameters and kinetics of fibrinogen polymerization in patients with multiple myeloma at diagnosisW Nowak, J Treliński, K Chojnowski, et al.Medical Oncology (Northwood, London, England)|October 16, 2016
A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinomaFeng-Hua Wang, Yun Wang, Zhen-Dong Chen, et al.Medical Oncology (Northwood, London, England)|May 6, 2014
Combining bevacizumab and panitumumab with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as second-line treatment in patients with metastatic colorectal cancerHong-Liang Liang, Ai-Ping Hu, Sen-Lin Li, et al.Medical Oncology (Northwood, London, England)|May 6, 2014
Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with SorafenibKai Wei, Meng Wang, Wei Zhang, et al.Medical Oncology (Northwood, London, England)|May 6, 2014
Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in JapanHideaki Miyake, Akira Miyazaki, Ken-Ichi Harada, et al.Medical Oncology (Northwood, London, England)|February 6, 2014
Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancerYe Won Jeon, Seung Taek Lim, Hyun Joo Choi, et al.Pageof 573